Moderna Downgraded To Market Perform From Outperform At BMO Capital
November 17, 2020 at 08:48 AM EST
BMO Capital analyst George Farmer downgraded Moderna to Market Perform from Outperform with a $109 price target.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.